Although the relevance of plasma ACE2 to susceptibility to SARS‐CoV‐2 (which binds to cell surface ACE2)4 is unclear, this study also fails to provide evidence in support of the theoretical risks of ACEi/ARB with respect to COVID‐19. This evidence concerns the gene ACE2 and COVID-19.